Pneumonia · adults receiving EN via nasogastric or gastrostomy tube
It is very uncertain whether higher threshold (500 mL per six hours or greater) changes pneumonia (until discontinued or up to 28 days) compared with lower threshold (less than 500 mL per six hours) at time of aspiration (very low certainty).
1 finding from 1 review
Length of hospital stay · adults receiving EN via nasogastric or gastrostomy tube
1 finding from 1 review
ICU length of stay (days) and healthcare costs · adults requiring an artificial airway with or without mechanical ventilator support
1 finding from 1 review
Duration of ICU stay · adults requiring an artificial airway with or without mechanical ventilator support
1 finding from 1 review
Procedural complications · DCM (non‐ischaemic)
1 finding from 1 review
Number of responders · IBD patients
1 finding from 1 review
Serious adverse events ‐ active or inactive disease (14 days) · IBD patients
It is very uncertain whether oral iron sulphate changes serious adverse events ‐ active or inactive disease (14 days) compared with oral iron hydroxide polymaltose complex (very low certainty).
1 finding from 1 review
Pain frequency IBD (measured in days of pain on the IBS‐SSS questionnaire) · people with inflammatory bowel disease
1 finding from 1 review
Pain frequency or change in pain frequency · people with inflammatory bowel disease
1 finding from 1 review
Pain frequency CD (measured in days of pain on the IBS‐SSS questionnaire) · people with inflammatory bowel disease
1 finding from 1 review
Physical activity · people with NMD
1 finding from 1 review
Negative PCR for SARS‐CoV‐2 on respiratory samples at day 14 from enrolmentd · adults with mild to severe COVID‐19
Hydroxychloroquine (HCQ) showed no clear difference in negative PCR for SARS‐CoV‐2 on respiratory samples at day 14 from… compared with standard care or placebo (low certainty).
1 finding from 1 review
Development of confirmed COVID‐19 at 14 days from enrolment · people who have been exposed to SARS‐CoV‐2
It is very uncertain whether hydroxychloroquine (HCQ) changes development of confirmed COVID‐19 at 14 days from enrolment compared with placebo (very low certainty).
1 finding from 1 review
Pain frequency or change in pain frequency · UC patients
1 finding from 1 review
QoL · pressure ulcer prevention
2 findings from 1 review
QoL · pressure ulcer prevention
2 findings from 1 review
30‐Day mortality · adults with clinically diagnosed AAA deemed suitable for elective repair
It is very uncertain whether exercise changes 30‐day mortality compared with no exercise (very low certainty).
1 finding from 1 review
Duration of ICU stay · adults with clinically diagnosed AAA deemed suitable for elective repair
1 finding from 1 review
Length of hospital stay · adults with clinically diagnosed AAA deemed suitable for elective repair
1 finding from 1 review
Days on ventilator · adults with clinically diagnosed AAA deemed suitable for elective repair
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found